Da den systemiske eksponering overfor frit cytarabin efter intratekal DepoCyte behandling er ubetydelig, er risikoen for nedsat fertilitet sandsynligvis lille.
Because the systemic exposure to free cytarabine following intrathecal treatment with DepoCyte was negligible, the risk of impaired fertility is likely to be low.